Stromal fibroblasts in cancer initiation and progression (original) (raw)
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature396, 643–649 (1998). ADSCASPubMed Google Scholar
Ronnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev.76, 69–125 (1996). CASPubMed Google Scholar
Tlsty, T. D. & Hein, P. W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev.11, 54–59 (2001). CASPubMed Google Scholar
Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature407, 249–257 (2000). CASPubMed Google Scholar
Sandler, A. B., Johnson, D. H. & Herbst, R. S. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer. Clin. Cancer Res.10, 4258s–4262s (2004). CASPubMed Google Scholar
Weaver, V. M. et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol.137, 231–245 (1997). CASPubMedPubMed Central Google Scholar
Ronnov-Jessen, L., Petersen, O. W., Koteliansky, V. E. & Bissell, M. J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumour environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest.95, 859–873 (1995). CASPubMedPubMed Central Google Scholar
Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Rev. Cancer3, 422–433 (2003). CAS Google Scholar
Cunha, G. R., Reese, B. A. & Sekkingstad, M. Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice. Endocrinology107, 1767–1770 (1980). CASPubMed Google Scholar
Xin, L., Ide, H., Kim, Y., Dubey, P. & Witte, O. N. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl Acad. Sci. USA100 (suppl. 1), 11896–11903 (2003). ADSCASPubMedPubMed Central Google Scholar
Cunha, G. R., Bigsby, R. M., Cooke, P. S. & Sugimura, Y. Stromal-epithelial interactions in adult organs. Cell Differ.17, 137–148 (1985). CASPubMed Google Scholar
Culig, Z. et al. Regulation of prostatic growth and function by peptide growth factors. Prostate28, 392–405 (1996). CASPubMed Google Scholar
Cunha, G. R. & Donjacour, A. A. Mesenchymal-epithelial interactions in the growth and development of the prostate. Cancer Treat. Res.46, 159–75 (1989). CASPubMed Google Scholar
Hayward, S. W. Approaches to modeling stromal–epithelial interactions. J. Urol.168, 1165–1172 (2002). PubMed Google Scholar
Hayward, S. W. & Cunha, G. R. The prostate: development and physiology. Radiol. Clin. North Am.38, 1–14 (2000). CASPubMed Google Scholar
Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nature Med.10, 789–799 (2004). CASPubMed Google Scholar
Dawe, C. J. in Tissue Interactions in Carcinogenesis. (ed. Tarin, D.) 305–358 (Academic, London, 1972). Google Scholar
Schor, S. L., Schor, A. M. & Rushton, G. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J. Cell Sci.90, 401–407 (1988). PubMed Google Scholar
Schor, S. L., Schor, A. M., Rushton, G. & Smith, L. Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during foetal development J. Cell Sci.73, 221–234 (1985). CASPubMed Google Scholar
Russell, P. J., Bennett, S. & Stricker, P. Growth factor involvement in progression of prostate cancer. Clin. Chem.44, 705–723 (1998). CASPubMed Google Scholar
Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumour progression of initiated human prostatic epithelium. Cancer Res.59, 5002–11 (1999). CASPubMed Google Scholar
Hayward, S. W. et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res.61, 8135–8142 (2001). CASPubMed Google Scholar
Barcellos-Hoff, M. H. & Ravani, S. A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res.60, 1254–1260 (2000). CASPubMed Google Scholar
Ohuchida, K. et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumour–stromal interactions. Cancer Res.64, 3215–3222 (2004). CASPubMed Google Scholar
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA98, 12072–12077 (2001). ADSCASPubMedPubMed Central Google Scholar
Allinen, M. et al. Molecular characterization of the tumour microenvironment in breast cancer. Cancer Cell6, 17–32 (2004). CASPubMed Google Scholar
Tucker, R. F., Shipley, G. D., Moses, H. L. & Holley, R. W. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science226, 705–777 (1984). ADSCASPubMed Google Scholar
Moses, H. L. et al. Type β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells3, 65–71 (1985). CAS Google Scholar
Pierce, D. F. Jr et al. Mammary tumour suppression by transforming growth factor beta 1 transgene expression. Proc. Natl Acad. Sci. USA92, 4254–4258 (1995). ADSCASPubMedPubMed Central Google Scholar
Bottinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. & Wakefield, L. M. Transgenic mice overexpressing a dominant–negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7, 12-dimethylbenz-[a]-anthracene. Cancer Res.57, 5564–5570 (1997). CASPubMed Google Scholar
Gorska, A. E. et al. Transgenic mice expressing a dominant–negative mutant type II TGF-β receptor have impaired mammary development and enhanced mammary tumour formation. Am. J. Pathol.163, 1539–1549 (2003). CASPubMedPubMed Central Google Scholar
Amendt, C., Schirmacher, P., Weber, H. & Blessing, M. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene17, 25–34 (1998). CASPubMed Google Scholar
Akhurst, R. J. & Derynck, R. TGF-beta signalling in cancer–a double-edged sword. Trends Cell Biol.11, S44–S51 (2001). CASPubMed Google Scholar
Gold, L. I. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit. Rev. Oncog.10, 303–360 (1999). CASPubMed Google Scholar
Tsushima, H. et al. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin. Cancer Res.7, 1258–1262 (2001). CASPubMed Google Scholar
Shariat, S. F. et al. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. J. Clin. Oncol.19, 2856–2864 (2001). CASPubMed Google Scholar
Shariat, S. F. et al. Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer92, 2985–2992 (2001). CASPubMed Google Scholar
Bhowmick, N. A. et al. TGF-beta signalling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science303, 848–851 (2004). ADSCASPubMed Google Scholar
Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA101, 4966–4971 (2004). ADSCASPubMedPubMed Central Google Scholar
Nakamura, T., Matsumoto, K., Kiritoshi, A. & Tano, Y. Induction of hepatocyte growth factor in fibroblasts by tumour-derived factors affects invasive growth of tumour cells_: in vitro_ analysis of tumour–stromal interactions. Cancer Res.57, 3305–3313 (1997). CASPubMed Google Scholar
Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol.4, 915–925 (2003). CAS Google Scholar
Michieli, P. et al. Targeting the tumour and its microenvironment by a dual-function decoy Met receptor. Cancer Cell6, 61–73 (2004). CASPubMed Google Scholar
Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell3, 347–361 (2003). PubMed Google Scholar
Massague, J., Blain, S. W. & Lo, R. S. TGF-beta signalling in growth control, cancer, and heritable disorders. Cell103, 295–309 (2000). CASPubMed Google Scholar
Koskinen, P. J., Sistonen, L., Bravo, R. & Alitalo, K. Immediate early gene responses of NIH 3T3 fibroblasts and NMuMG epithelial cells to TGF beta-1. Growth Factors5, 283–293 (1991). CASPubMed Google Scholar
Lynch, C. C. & Matrisian, L. M. Matrix metalloproteinases in tumour-host cell communication. Differentiation70, 561–573 (2002). CASPubMed Google Scholar
Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer2, 161–174 (2002). CAS Google Scholar
Itoh, T. et al. Reduced angiogenesis and tumour progression in gelatinase A-deficient mice. Cancer Res.58, 1048–1051 (1998). CASPubMed Google Scholar
Brauchle, M., Angermeyer, K., Hubner, G. & Werner, S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene9, 3199–3204 (1994). CASPubMed Google Scholar
Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F. & McKeehan, W. L. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol. Endocrinol.6, 2123–2128 (1992). CASPubMed Google Scholar
Lu, W., Luo, Y., Kan, M. & McKeehan, W. L. Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate. J. Biol. Chem.274, 12827–12834 (1999). CASPubMed Google Scholar
Jin, C. et al. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumours. Cancer Res.64, 4555–4562 (2004). CASPubMed Google Scholar
Furuhashi, M. et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumours and an associated increase in tumour growth rate. Cancer Res.64, 2725–2733 (2004). CASPubMed Google Scholar
Jue, S. F., Bradley, R. S., Rudnicki, J. A., Varmus, H. E. & Brown, A. M. The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. Mol. Cell. Biol.12, 321–328 (1992). CASPubMedPubMed Central Google Scholar
Derksen, P. W. et al. Illegitimate WNT signalling promotes proliferation of multiple myeloma cells. Proc. Natl Acad. Sci. USA101, 6122–6127 (2004). ADSCASPubMedPubMed Central Google Scholar
Marnett, L. J., Riggins, J. N. & West, J. D. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest.111, 583–593 (2003). CASPubMedPubMed Central Google Scholar
Moinfar, F. et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res.60, 2562–2566 (2000). CASPubMed Google Scholar
Kurose, K. et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet.32, 355–357 (2002). CASPubMed Google Scholar
Xue, C., Plieth, D., Venkov, C., Xu, C. & Neilson, E. G. The gatekeeper effect of epithelial–mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res.63, 3386–3394 (2003). CASPubMed Google Scholar
Jacoby, R. F. et al. A juvenile polyposis tumour suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology112, 1398–1403 (1997). CASPubMed Google Scholar
Wirtzfeld, D. A., Petrelli, N. J. & Rodriguez-Bigas, M. A. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann. Surg. Oncol.8, 319–327 (2001). CASPubMed Google Scholar
Waite, K. A. & Eng, C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nature Rev. Genet.4, 763–773 (2003). ADSCASPubMed Google Scholar
Yang, Y. A. et al. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest.109, 1607–1615 (2002). CASPubMedPubMed Central Google Scholar
Trusolino, L. & Comoglio, P. M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nature Rev. Cancer2, 289–300 (2002). CAS Google Scholar
Wessells, N. K. Mammalian lung development: interactions in formation and morphogenesis of tracheal buds. J. Exp. Zool.175, 455–466 (1970). CASPubMed Google Scholar
Bellusci, S. et al. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development124, 53–63 (1997). CASPubMed Google Scholar